“With big Pharma having the largest lobbying group in DC this hardly comes as a surprise.” Admin
The new head of the Food and Drug Administration (FDA) selected by President Barack Obama has very close ties to the pharmaceutical industry.
Dr. Robert Califf, an FDA deputy commissioner and cardiologist at Duke University, has had considerable dealings, including financial ones, with drug manufacturers, whose products must be approved by the agency he’s been tabbed to lead.
“No one who knows him thinks he wants to weaken the regulatory agency he has been chosen to lead,” The New York Times reported. “But he has deeper ties to the pharmaceutical industry than any FDA commissioner in recent memory, and some public health advocates question whether his background could tilt him in the direction of an industry he would be in charge of supervising.”
Read More: Controversies – Obama’s Nominee for FDA Chief Scrutinized for Ties to Big Pharma – AllGov – News
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr